Table 4 Cox cause-specific hazard ratios (csHR), subdistribution hazard ratios (subHR), and associated 95% confidence intervals for evaluating the treatment effect; adjusted for nodal status and both tumour size.
From: Analysis and design of randomised clinical trials involving competing risks endpoints
| Â | Adjusted for nodal status and tumour size | |
|---|---|---|
Competing event | csHR | subHR |
M: Distant metastasis | 0.39 (0.22 - 0.71) | 0.42 (0.23 - 0.79) |
R: Loco-regional recurrence | 0.69 (0.27 - 1.79) | 0.81 (0.30 - 2.17) |